nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—ABCC4—Methotrexate—multiple sclerosis	0.0653	0.485	CbGbCtD
Adefovir Dipivoxil—NME2—Nucleotide Metabolism—SRM—multiple sclerosis	0.0413	0.155	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Methotrexate—multiple sclerosis	0.0408	0.303	CbGbCtD
Adefovir Dipivoxil—NME2—pineal body—multiple sclerosis	0.0342	0.167	CbGeAlD
Adefovir Dipivoxil—AK2—Synthesis and interconversion of nucleotide di- and triphosphates—RRM1—multiple sclerosis	0.0332	0.124	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Methotrexate—multiple sclerosis	0.0284	0.211	CbGbCtD
Adefovir Dipivoxil—NME2—Synthesis and interconversion of nucleotide di- and triphosphates—RRM1—multiple sclerosis	0.023	0.0863	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Nucleotide Metabolism—RRM1—multiple sclerosis	0.0221	0.0826	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Synthesis and interconversion of nucleotide di- and triphosphates—RRM1—multiple sclerosis	0.0175	0.0654	CbGpPWpGaD
Adefovir Dipivoxil—NME2—brainstem—multiple sclerosis	0.0107	0.0521	CbGeAlD
Adefovir Dipivoxil—AK4—retina—multiple sclerosis	0.0105	0.0515	CbGeAlD
Adefovir Dipivoxil—NME2—retina—multiple sclerosis	0.0103	0.0503	CbGeAlD
Adefovir Dipivoxil—AK2—Nucleotide metabolism—RRM1—multiple sclerosis	0.0103	0.0385	CbGpPWpGaD
Adefovir Dipivoxil—AK4—medulla oblongata—multiple sclerosis	0.00761	0.0372	CbGeAlD
Adefovir Dipivoxil—AK2—cerebellum—multiple sclerosis	0.00727	0.0355	CbGeAlD
Adefovir Dipivoxil—NME2—Nucleotide metabolism—RRM1—multiple sclerosis	0.00713	0.0267	CbGpPWpGaD
Adefovir Dipivoxil—AK4—midbrain—multiple sclerosis	0.00696	0.034	CbGeAlD
Adefovir Dipivoxil—AK4—spinal cord—multiple sclerosis	0.00679	0.0332	CbGeAlD
Adefovir Dipivoxil—ABCC5—retina—multiple sclerosis	0.00598	0.0292	CbGeAlD
Adefovir Dipivoxil—NME1—nervous system—multiple sclerosis	0.00593	0.029	CbGeAlD
Adefovir Dipivoxil—AK2—brain—multiple sclerosis	0.00591	0.0289	CbGeAlD
Adefovir Dipivoxil—ABCC5—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.0058	0.0217	CbGpPWpGaD
Adefovir Dipivoxil—AK4—nervous system—multiple sclerosis	0.00572	0.0279	CbGeAlD
Adefovir Dipivoxil—NME1—central nervous system—multiple sclerosis	0.00571	0.0279	CbGeAlD
Adefovir Dipivoxil—NME2—nervous system—multiple sclerosis	0.00559	0.0273	CbGeAlD
Adefovir Dipivoxil—NME1—cerebellum—multiple sclerosis	0.00558	0.0273	CbGeAlD
Adefovir Dipivoxil—AK4—central nervous system—multiple sclerosis	0.00551	0.0269	CbGeAlD
Adefovir Dipivoxil—NME1—Nucleotide metabolism—RRM1—multiple sclerosis	0.0054	0.0202	CbGpPWpGaD
Adefovir Dipivoxil—AK4—cerebellum—multiple sclerosis	0.00538	0.0263	CbGeAlD
Adefovir Dipivoxil—NME2—central nervous system—multiple sclerosis	0.00538	0.0263	CbGeAlD
Adefovir Dipivoxil—NME2—cerebellum—multiple sclerosis	0.00526	0.0257	CbGeAlD
Adefovir Dipivoxil—NME1—brain—multiple sclerosis	0.00454	0.0222	CbGeAlD
Adefovir Dipivoxil—NME1—Arf6 trafficking events—ITGA4—multiple sclerosis	0.00444	0.0166	CbGpPWpGaD
Adefovir Dipivoxil—AK4—brain—multiple sclerosis	0.00437	0.0214	CbGeAlD
Adefovir Dipivoxil—ABCC5—medulla oblongata—multiple sclerosis	0.00432	0.0211	CbGeAlD
Adefovir Dipivoxil—NME2—brain—multiple sclerosis	0.00427	0.0209	CbGeAlD
Adefovir Dipivoxil—ABCC4—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.00402	0.0151	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—midbrain—multiple sclerosis	0.00395	0.0193	CbGeAlD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—BDNF—multiple sclerosis	0.0035	0.0131	CbGpPWpGaD
Adefovir Dipivoxil—Myopathy—Triamcinolone—multiple sclerosis	0.0035	0.00913	CcSEcCtD
Adefovir Dipivoxil—Myopathy—Methylprednisolone—multiple sclerosis	0.00349	0.00911	CcSEcCtD
Adefovir Dipivoxil—Bone pain—Mitoxantrone—multiple sclerosis	0.0034	0.00886	CcSEcCtD
Adefovir Dipivoxil—NME1—Arf6 downstream pathway—MAPK1—multiple sclerosis	0.00339	0.0127	CbGpPWpGaD
Adefovir Dipivoxil—Hepatic function abnormal—Azathioprine—multiple sclerosis	0.00334	0.00872	CcSEcCtD
Adefovir Dipivoxil—Multiple fractures—Prednisone—multiple sclerosis	0.00334	0.00871	CcSEcCtD
Adefovir Dipivoxil—Fracture—Prednisone—multiple sclerosis	0.00334	0.00871	CcSEcCtD
Adefovir Dipivoxil—Cough—Fingolimod—multiple sclerosis	0.00333	0.00869	CcSEcCtD
Adefovir Dipivoxil—Hepatic failure—Azathioprine—multiple sclerosis	0.00325	0.00848	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.00323	0.00842	CcSEcCtD
Adefovir Dipivoxil—Hyperkalaemia—Mitoxantrone—multiple sclerosis	0.0032	0.00834	CcSEcCtD
Adefovir Dipivoxil—Myopathy—Dexamethasone—multiple sclerosis	0.00318	0.00829	CcSEcCtD
Adefovir Dipivoxil—Myopathy—Betamethasone—multiple sclerosis	0.00318	0.00829	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Fingolimod—multiple sclerosis	0.00306	0.00797	CcSEcCtD
Adefovir Dipivoxil—ABCC5—cerebellum—multiple sclerosis	0.00306	0.0149	CbGeAlD
Adefovir Dipivoxil—Glycosuria—Triamcinolone—multiple sclerosis	0.00303	0.00791	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Fingolimod—multiple sclerosis	0.00303	0.0079	CcSEcCtD
Adefovir Dipivoxil—Glycosuria—Methylprednisolone—multiple sclerosis	0.00302	0.00789	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.00295	0.0111	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—AHI1—multiple sclerosis	0.00294	0.011	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—brain—multiple sclerosis	0.00285	0.0139	CbGeAlD
Adefovir Dipivoxil—Fracture—Methotrexate—multiple sclerosis	0.00279	0.00728	CcSEcCtD
Adefovir Dipivoxil—Multiple fractures—Methotrexate—multiple sclerosis	0.00279	0.00728	CcSEcCtD
Adefovir Dipivoxil—Myopathy—Prednisone—multiple sclerosis	0.00277	0.00722	CcSEcCtD
Adefovir Dipivoxil—Glycosuria—Betamethasone—multiple sclerosis	0.00275	0.00717	CcSEcCtD
Adefovir Dipivoxil—Glycosuria—Dexamethasone—multiple sclerosis	0.00275	0.00717	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Cladribine—multiple sclerosis	0.00272	0.0071	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00269	0.00702	CcSEcCtD
Adefovir Dipivoxil—Cough increased—Triamcinolone—multiple sclerosis	0.00268	0.007	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.00264	0.00988	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.00262	0.254	CbGdCrCtD
Adefovir Dipivoxil—Hepatobiliary disease—Cladribine—multiple sclerosis	0.00262	0.00683	CcSEcCtD
Adefovir Dipivoxil—NME1—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.00258	0.25	CbGdCrCtD
Adefovir Dipivoxil—NME1—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.00258	0.25	CbGdCrCtD
Adefovir Dipivoxil—NME1—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.00252	0.245	CbGdCrCtD
Adefovir Dipivoxil—ABCC5—Defective B3GAT3 causes JDSSDHD—GPC5—multiple sclerosis	0.00251	0.0094	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—brain—multiple sclerosis	0.00248	0.0121	CbGeAlD
Adefovir Dipivoxil—Pancreatitis—Azathioprine—multiple sclerosis	0.00248	0.00646	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Cladribine—multiple sclerosis	0.00247	0.00644	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Cladribine—multiple sclerosis	0.00246	0.0064	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Cladribine—multiple sclerosis	0.00244	0.00637	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Cladribine—multiple sclerosis	0.00244	0.00636	CcSEcCtD
Adefovir Dipivoxil—Glycosuria—Prednisone—multiple sclerosis	0.0024	0.00625	CcSEcCtD
Adefovir Dipivoxil—Liver disorder—Methotrexate—multiple sclerosis	0.00238	0.0062	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—nervous system—multiple sclerosis	0.00232	0.0113	CbGeAlD
Adefovir Dipivoxil—ABCC4—nervous system—multiple sclerosis	0.00225	0.011	CbGeAlD
Adefovir Dipivoxil—Asthenia—Fingolimod—multiple sclerosis	0.00224	0.00583	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—central nervous system—multiple sclerosis	0.00223	0.0109	CbGeAlD
Adefovir Dipivoxil—SLC22A8—nervous system—multiple sclerosis	0.00223	0.0109	CbGeAlD
Adefovir Dipivoxil—Blood creatinine increased—Mitoxantrone—multiple sclerosis	0.00221	0.00577	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Fingolimod—multiple sclerosis	0.0022	0.00575	CcSEcCtD
Adefovir Dipivoxil—ABCC4—central nervous system—multiple sclerosis	0.00217	0.0106	CbGeAlD
Adefovir Dipivoxil—Malnutrition—Cladribine—multiple sclerosis	0.00216	0.00565	CcSEcCtD
Adefovir Dipivoxil—SLC22A8—central nervous system—multiple sclerosis	0.00215	0.0105	CbGeAlD
Adefovir Dipivoxil—Flatulence—Cladribine—multiple sclerosis	0.00213	0.00556	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Fingolimod—multiple sclerosis	0.00213	0.00556	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—PLEK—multiple sclerosis	0.00213	0.00798	CbGpPWpGaD
Adefovir Dipivoxil—Hepatobiliary disease—Azathioprine—multiple sclerosis	0.00213	0.00556	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.00211	0.00792	CbGpPWpGaD
Adefovir Dipivoxil—Back pain—Cladribine—multiple sclerosis	0.00209	0.00546	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Mitoxantrone—multiple sclerosis	0.00208	0.00543	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	0.00203	0.0076	CbGpPWpGaD
Adefovir Dipivoxil—Anaemia—Cladribine—multiple sclerosis	0.002	0.00522	CcSEcCtD
Adefovir Dipivoxil—Headache—Fingolimod—multiple sclerosis	0.00195	0.00509	CcSEcCtD
Adefovir Dipivoxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.00191	0.00714	CbGpPWpGaD
Adefovir Dipivoxil—Cough—Cladribine—multiple sclerosis	0.00189	0.00493	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Mitoxantrone—multiple sclerosis	0.00185	0.00482	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Cladribine—multiple sclerosis	0.00184	0.00481	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Cladribine—multiple sclerosis	0.00184	0.00481	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00183	0.00477	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Mitoxantrone—multiple sclerosis	0.00179	0.00467	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Mitoxantrone—multiple sclerosis	0.00177	0.00463	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—brain—multiple sclerosis	0.00177	0.00867	CbGeAlD
Adefovir Dipivoxil—AK2—Metabolism—SRM—multiple sclerosis	0.00175	0.00655	CbGpPWpGaD
Adefovir Dipivoxil—Haematuria—Mitoxantrone—multiple sclerosis	0.00174	0.00453	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Cladribine—multiple sclerosis	0.00173	0.00452	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Cladribine—multiple sclerosis	0.00173	0.00451	CcSEcCtD
Adefovir Dipivoxil—ABCC4—brain—multiple sclerosis	0.00172	0.00841	CbGeAlD
Adefovir Dipivoxil—Skin disorder—Cladribine—multiple sclerosis	0.00172	0.00448	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Mitoxantrone—multiple sclerosis	0.00171	0.00446	CcSEcCtD
Adefovir Dipivoxil—SLC22A8—brain—multiple sclerosis	0.00171	0.00834	CbGeAlD
Adefovir Dipivoxil—Anorexia—Cladribine—multiple sclerosis	0.00168	0.00439	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Prednisolone—multiple sclerosis	0.00164	0.00428	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Mitoxantrone—multiple sclerosis	0.00163	0.00426	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Azathioprine—multiple sclerosis	0.00163	0.00424	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Mitoxantrone—multiple sclerosis	0.00162	0.00423	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.00161	0.0042	CcSEcCtD
Adefovir Dipivoxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.00159	0.00596	CbGpPWpGaD
Adefovir Dipivoxil—Alanine aminotransferase increased—Methylprednisolone—multiple sclerosis	0.00157	0.00409	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Cladribine—multiple sclerosis	0.00154	0.00401	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00153	0.00398	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Triamcinolone—multiple sclerosis	0.00151	0.00394	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Methylprednisolone—multiple sclerosis	0.00151	0.00393	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Azathioprine—multiple sclerosis	0.0015	0.00391	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00149	0.00388	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.00148	0.00553	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—MMP9—multiple sclerosis	0.00147	0.00549	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.00145	0.00541	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00144	0.00377	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Azathioprine—multiple sclerosis	0.00141	0.00367	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Cladribine—multiple sclerosis	0.0014	0.00364	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Cladribine—multiple sclerosis	0.0014	0.00364	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Azathioprine—multiple sclerosis	0.0014	0.00364	CcSEcCtD
Adefovir Dipivoxil—Back pain—Mitoxantrone—multiple sclerosis	0.00138	0.00359	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Carbohydrate metabolism—GPC5—multiple sclerosis	0.00135	0.00505	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.00133	0.00499	CbGpPWpGaD
Adefovir Dipivoxil—Anaemia—Mitoxantrone—multiple sclerosis	0.00132	0.00343	CcSEcCtD
Adefovir Dipivoxil—Hepatic failure—Methotrexate—multiple sclerosis	0.00131	0.00342	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.00131	0.00341	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Cladribine—multiple sclerosis	0.00127	0.00331	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00127	0.00475	CbGpPWpGaD
Adefovir Dipivoxil—Weight decreased—Betamethasone—multiple sclerosis	0.00126	0.0033	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Dexamethasone—multiple sclerosis	0.00126	0.0033	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Cladribine—multiple sclerosis	0.00125	0.00326	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Prednisone—multiple sclerosis	0.00124	0.00324	CcSEcCtD
Adefovir Dipivoxil—Cough—Mitoxantrone—multiple sclerosis	0.00124	0.00324	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00124	0.00323	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—CYP24A1—multiple sclerosis	0.00123	0.00462	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—CYP27B1—multiple sclerosis	0.00123	0.00462	CbGpPWpGaD
Adefovir Dipivoxil—Pharyngitis—Triamcinolone—multiple sclerosis	0.00122	0.00319	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—SRM—multiple sclerosis	0.00121	0.00454	CbGpPWpGaD
Adefovir Dipivoxil—Chest pain—Mitoxantrone—multiple sclerosis	0.00121	0.00316	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Mitoxantrone—multiple sclerosis	0.00121	0.00316	CcSEcCtD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—MYC—multiple sclerosis	0.00121	0.00453	CbGpPWpGaD
Adefovir Dipivoxil—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.00121	0.00315	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Cladribine—multiple sclerosis	0.00121	0.00315	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Prednisone—multiple sclerosis	0.00119	0.00311	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00117	0.00306	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.00116	0.00435	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00114	0.00428	CbGpPWpGaD
Adefovir Dipivoxil—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.00114	0.00297	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Azathioprine—multiple sclerosis	0.00114	0.00296	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Azathioprine—multiple sclerosis	0.00114	0.00296	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Mitoxantrone—multiple sclerosis	0.00113	0.00294	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—GPC5—multiple sclerosis	0.00113	0.00422	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Cladribine—multiple sclerosis	0.00112	0.00293	CcSEcCtD
Adefovir Dipivoxil—Rash—Cladribine—multiple sclerosis	0.00111	0.00291	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Cladribine—multiple sclerosis	0.00111	0.0029	CcSEcCtD
Adefovir Dipivoxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.00111	0.00416	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—MMP9—multiple sclerosis	0.00111	0.00416	CbGpPWpGaD
Adefovir Dipivoxil—Anorexia—Mitoxantrone—multiple sclerosis	0.00111	0.00289	CcSEcCtD
Adefovir Dipivoxil—Headache—Cladribine—multiple sclerosis	0.00111	0.00289	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Prednisone—multiple sclerosis	0.0011	0.00287	CcSEcCtD
Adefovir Dipivoxil—Liver function test abnormal—Methotrexate—multiple sclerosis	0.00109	0.00283	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Methylprednisolone—multiple sclerosis	0.00107	0.00279	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.00106	0.00276	CcSEcCtD
Adefovir Dipivoxil—Nausea—Cladribine—multiple sclerosis	0.00105	0.00274	CcSEcCtD
Adefovir Dipivoxil—Back pain—Triamcinolone—multiple sclerosis	0.00104	0.00271	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00102	0.00267	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00101	0.00263	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Methotrexate—multiple sclerosis	0.000998	0.0026	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000993	0.00372	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Azathioprine—multiple sclerosis	0.000983	0.00256	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00096	0.0036	CbGpPWpGaD
Adefovir Dipivoxil—Connective tissue disorder—Prednisone—multiple sclerosis	0.000958	0.0025	CcSEcCtD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000953	0.00357	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00095	0.00248	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	0.000945	0.00354	CbGpPWpGaD
Adefovir Dipivoxil—Cough—Triamcinolone—multiple sclerosis	0.000937	0.00244	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—RRM1—multiple sclerosis	0.000934	0.0035	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—SRM—multiple sclerosis	0.000919	0.00344	CbGpPWpGaD
Adefovir Dipivoxil—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000918	0.00239	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000918	0.00239	CcSEcCtD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—MYC—multiple sclerosis	0.000917	0.00344	CbGpPWpGaD
Adefovir Dipivoxil—Myalgia—Triamcinolone—multiple sclerosis	0.000914	0.00238	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Azathioprine—multiple sclerosis	0.000913	0.00238	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Methylprednisolone—multiple sclerosis	0.000912	0.00238	CcSEcCtD
Adefovir Dipivoxil—Rash—Azathioprine—multiple sclerosis	0.000906	0.00236	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000906	0.00236	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Azathioprine—multiple sclerosis	0.000905	0.00236	CcSEcCtD
Adefovir Dipivoxil—Headache—Azathioprine—multiple sclerosis	0.0009	0.00235	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Methotrexate—multiple sclerosis	0.000892	0.00233	CcSEcCtD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000866	0.00324	CbGpPWpGaD
Adefovir Dipivoxil—Haematuria—Methotrexate—multiple sclerosis	0.000865	0.00226	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000858	0.00224	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000857	0.00224	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—CYP27B1—multiple sclerosis	0.000854	0.0032	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CYP24A1—multiple sclerosis	0.000854	0.0032	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Azathioprine—multiple sclerosis	0.000853	0.00223	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Methylprednisolone—multiple sclerosis	0.000849	0.00221	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Prednisone—multiple sclerosis	0.000848	0.00221	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Mitoxantrone—multiple sclerosis	0.000833	0.00217	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Dexamethasone—multiple sclerosis	0.000829	0.00216	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Betamethasone—multiple sclerosis	0.000829	0.00216	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Methotrexate—multiple sclerosis	0.000814	0.00212	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Methotrexate—multiple sclerosis	0.000808	0.00211	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000804	0.0021	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000803	0.00301	CbGpPWpGaD
Adefovir Dipivoxil—Urethral disorder—Methotrexate—multiple sclerosis	0.000798	0.00208	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000798	0.00208	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000796	0.00208	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000795	0.00207	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Hemostasis—MERTK—multiple sclerosis	0.000789	0.00295	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—SELPLG—multiple sclerosis	0.000789	0.00295	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—CD58—multiple sclerosis	0.000789	0.00295	CbGpPWpGaD
Adefovir Dipivoxil—Anaemia—Prednisone—multiple sclerosis	0.000784	0.00204	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—GPC5—multiple sclerosis	0.000781	0.00293	CbGpPWpGaD
Adefovir Dipivoxil—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00078	0.00203	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Betamethasone—multiple sclerosis	0.00078	0.00203	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000778	0.00203	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000778	0.00203	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Triamcinolone—multiple sclerosis	0.000771	0.00201	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000769	0.00201	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Betamethasone—multiple sclerosis	0.000758	0.00198	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Dexamethasone—multiple sclerosis	0.000758	0.00198	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Mitoxantrone—multiple sclerosis	0.000738	0.00193	CcSEcCtD
Adefovir Dipivoxil—Rash—Mitoxantrone—multiple sclerosis	0.000732	0.00191	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Mitoxantrone—multiple sclerosis	0.000732	0.00191	CcSEcCtD
Adefovir Dipivoxil—Headache—Mitoxantrone—multiple sclerosis	0.000727	0.0019	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000724	0.00189	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000724	0.00189	CcSEcCtD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000723	0.00271	CbGpPWpGaD
Adefovir Dipivoxil—Myalgia—Prednisone—multiple sclerosis	0.000722	0.00188	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000717	0.00187	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000715	0.00186	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Methotrexate—multiple sclerosis	0.000709	0.00185	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Dexamethasone—multiple sclerosis	0.0007	0.00183	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Betamethasone—multiple sclerosis	0.0007	0.00183	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Triamcinolone—multiple sclerosis	0.000693	0.00181	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000691	0.0018	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Dexamethasone—multiple sclerosis	0.000691	0.0018	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Betamethasone—multiple sclerosis	0.000691	0.0018	CcSEcCtD
Adefovir Dipivoxil—Nausea—Mitoxantrone—multiple sclerosis	0.00069	0.0018	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000686	0.00179	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000686	0.00179	CcSEcCtD
Adefovir Dipivoxil—Back pain—Methotrexate—multiple sclerosis	0.000686	0.00179	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Prednisone—multiple sclerosis	0.000679	0.00177	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Prednisone—multiple sclerosis	0.000672	0.00175	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000671	0.00251	CbGpPWpGaD
Adefovir Dipivoxil—Anorexia—Prednisone—multiple sclerosis	0.00066	0.00172	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Methotrexate—multiple sclerosis	0.000655	0.00171	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00065	0.0017	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00065	0.0017	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—RRM1—multiple sclerosis	0.000647	0.00242	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CYP24A1—multiple sclerosis	0.000647	0.00242	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CYP27B1—multiple sclerosis	0.000647	0.00242	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000644	0.00241	CbGpPWpGaD
Adefovir Dipivoxil—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000631	0.00165	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Triamcinolone—multiple sclerosis	0.000629	0.00164	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Betamethasone—multiple sclerosis	0.000628	0.00164	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Dexamethasone—multiple sclerosis	0.000628	0.00164	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Dexamethasone—multiple sclerosis	0.000628	0.00164	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Betamethasone—multiple sclerosis	0.000628	0.00164	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Methylprednisolone—multiple sclerosis	0.000627	0.00164	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Triamcinolone—multiple sclerosis	0.00062	0.00162	CcSEcCtD
Adefovir Dipivoxil—Cough—Methotrexate—multiple sclerosis	0.000619	0.00161	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Methylprednisolone—multiple sclerosis	0.000618	0.00161	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Prednisone—multiple sclerosis	0.000609	0.00159	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000609	0.00228	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000605	0.00227	CbGpPWpGaD
Adefovir Dipivoxil—Myalgia—Methotrexate—multiple sclerosis	0.000604	0.00157	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Methotrexate—multiple sclerosis	0.000604	0.00157	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Prednisone—multiple sclerosis	0.000602	0.00157	CcSEcCtD
Adefovir Dipivoxil—Rash—Prednisolone—multiple sclerosis	0.000601	0.00157	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Prednisolone—multiple sclerosis	0.0006	0.00157	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000599	0.00156	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000598	0.00156	CcSEcCtD
Adefovir Dipivoxil—Headache—Prednisolone—multiple sclerosis	0.000597	0.00156	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—GPC5—multiple sclerosis	0.000592	0.00222	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00058	0.00217	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Betamethasone—multiple sclerosis	0.00057	0.00149	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Dexamethasone—multiple sclerosis	0.00057	0.00149	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Methotrexate—multiple sclerosis	0.000567	0.00148	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000566	0.00148	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000566	0.00148	CcSEcCtD
Adefovir Dipivoxil—Nausea—Prednisolone—multiple sclerosis	0.000566	0.00148	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Dexamethasone—multiple sclerosis	0.000562	0.00147	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Betamethasone—multiple sclerosis	0.000562	0.00147	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Methotrexate—multiple sclerosis	0.000562	0.00147	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Triamcinolone—multiple sclerosis	0.000557	0.00145	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000557	0.00208	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Methylprednisolone—multiple sclerosis	0.000556	0.00145	CcSEcCtD
Adefovir Dipivoxil—Rash—Triamcinolone—multiple sclerosis	0.000552	0.00144	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Triamcinolone—multiple sclerosis	0.000552	0.00144	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Methotrexate—multiple sclerosis	0.000552	0.00144	CcSEcCtD
Adefovir Dipivoxil—Rash—Methylprednisolone—multiple sclerosis	0.000551	0.00144	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Methylprednisolone—multiple sclerosis	0.000551	0.00144	CcSEcCtD
Adefovir Dipivoxil—Headache—Triamcinolone—multiple sclerosis	0.000549	0.00143	CcSEcCtD
Adefovir Dipivoxil—Headache—Methylprednisolone—multiple sclerosis	0.000548	0.00143	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Prednisone—multiple sclerosis	0.000547	0.00143	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Prednisone—multiple sclerosis	0.000547	0.00143	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Betamethasone—multiple sclerosis	0.000544	0.00142	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Dexamethasone—multiple sclerosis	0.000544	0.00142	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—BCHE—multiple sclerosis	0.000536	0.00201	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—ALB—multiple sclerosis	0.000536	0.00201	CbGpPWpGaD
Adefovir Dipivoxil—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000527	0.00137	CcSEcCtD
Adefovir Dipivoxil—Nausea—Triamcinolone—multiple sclerosis	0.00052	0.00136	CcSEcCtD
Adefovir Dipivoxil—Nausea—Methylprednisolone—multiple sclerosis	0.000519	0.00135	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—multiple sclerosis	0.000511	0.00191	CbGpPWpGaD
Adefovir Dipivoxil—Dyspepsia—Methotrexate—multiple sclerosis	0.000509	0.00133	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Dexamethasone—multiple sclerosis	0.000505	0.00132	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Betamethasone—multiple sclerosis	0.000505	0.00132	CcSEcCtD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000505	0.00189	CbGpPWpGaD
Adefovir Dipivoxil—Decreased appetite—Methotrexate—multiple sclerosis	0.000503	0.00131	CcSEcCtD
Adefovir Dipivoxil—Rash—Betamethasone—multiple sclerosis	0.000501	0.00131	CcSEcCtD
Adefovir Dipivoxil—Rash—Dexamethasone—multiple sclerosis	0.000501	0.00131	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Betamethasone—multiple sclerosis	0.000501	0.00131	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Dexamethasone—multiple sclerosis	0.000501	0.00131	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.0005	0.0013	CcSEcCtD
Adefovir Dipivoxil—Headache—Dexamethasone—multiple sclerosis	0.000498	0.0013	CcSEcCtD
Adefovir Dipivoxil—Headache—Betamethasone—multiple sclerosis	0.000498	0.0013	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Prednisone—multiple sclerosis	0.000497	0.0013	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Metabolism—SRM—multiple sclerosis	0.000496	0.00186	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—RRM1—multiple sclerosis	0.000491	0.00184	CbGpPWpGaD
Adefovir Dipivoxil—Pruritus—Prednisone—multiple sclerosis	0.00049	0.00128	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000488	0.00183	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PLEK—multiple sclerosis	0.000487	0.00182	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000484	0.00181	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000481	0.0018	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Prednisone—multiple sclerosis	0.000474	0.00124	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000473	0.00123	CcSEcCtD
Adefovir Dipivoxil—Nausea—Betamethasone—multiple sclerosis	0.000472	0.00123	CcSEcCtD
Adefovir Dipivoxil—Nausea—Dexamethasone—multiple sclerosis	0.000472	0.00123	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Methotrexate—multiple sclerosis	0.000457	0.00119	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Methotrexate—multiple sclerosis	0.000457	0.00119	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	0.000453	0.0017	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	0.000452	0.00169	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	0.000443	0.00166	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Prednisone—multiple sclerosis	0.00044	0.00115	CcSEcCtD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00044	0.00165	CbGpPWpGaD
Adefovir Dipivoxil—Rash—Prednisone—multiple sclerosis	0.000437	0.00114	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Prednisone—multiple sclerosis	0.000436	0.00114	CcSEcCtD
Adefovir Dipivoxil—Headache—Prednisone—multiple sclerosis	0.000434	0.00113	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000425	0.00159	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000422	0.00158	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	0.000422	0.00158	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Methotrexate—multiple sclerosis	0.000415	0.00108	CcSEcCtD
Adefovir Dipivoxil—Nausea—Prednisone—multiple sclerosis	0.000411	0.00107	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Methotrexate—multiple sclerosis	0.000409	0.00107	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Metabolism—SRM—multiple sclerosis	0.000398	0.00149	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Methotrexate—multiple sclerosis	0.000396	0.00103	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000386	0.00144	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—GPC5—multiple sclerosis	0.000382	0.00143	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—CCL2—multiple sclerosis	0.000372	0.00139	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—BCHE—multiple sclerosis	0.000372	0.00139	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Methotrexate—multiple sclerosis	0.000368	0.000959	CcSEcCtD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000367	0.00138	CbGpPWpGaD
Adefovir Dipivoxil—Rash—Methotrexate—multiple sclerosis	0.000365	0.000951	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Methotrexate—multiple sclerosis	0.000364	0.000951	CcSEcCtD
Adefovir Dipivoxil—Headache—Methotrexate—multiple sclerosis	0.000362	0.000945	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP27B1—multiple sclerosis	0.00035	0.00131	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP24A1—multiple sclerosis	0.00035	0.00131	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000348	0.0013	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Methotrexate—multiple sclerosis	0.000344	0.000896	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Hemostasis—SELE—multiple sclerosis	0.000343	0.00129	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000341	0.00128	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—TGFB1—multiple sclerosis	0.000339	0.00127	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000333	0.00125	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	0.000329	0.00123	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	0.000323	0.00121	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—APOE—multiple sclerosis	0.000323	0.00121	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GPC5—multiple sclerosis	0.00032	0.0012	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000307	0.00115	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—TGFB1—multiple sclerosis	0.000302	0.00113	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000295	0.0011	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00029	0.00109	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—BCHE—multiple sclerosis	0.000282	0.00106	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP27B1—multiple sclerosis	0.00028	0.00105	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP24A1—multiple sclerosis	0.00028	0.00105	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—POMC—multiple sclerosis	0.000277	0.00104	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—RRM1—multiple sclerosis	0.000265	0.000992	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000257	0.000961	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GPC5—multiple sclerosis	0.000256	0.00096	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—ALB—multiple sclerosis	0.000253	0.000947	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—RPL5—multiple sclerosis	0.000248	0.00093	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—ITGA4—multiple sclerosis	0.000248	0.000929	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IFNB1—multiple sclerosis	0.000246	0.000923	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000242	0.000905	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	0.000238	0.000891	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SLC11A1—multiple sclerosis	0.000238	0.000891	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—APOE—multiple sclerosis	0.000224	0.000838	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—MYC—multiple sclerosis	0.00022	0.000823	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000218	0.000816	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—RRM1—multiple sclerosis	0.000213	0.000796	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—TGFB1—multiple sclerosis	0.00021	0.000785	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	0.000193	0.000722	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—POMC—multiple sclerosis	0.000192	0.00072	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CD28—multiple sclerosis	0.00019	0.000711	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000182	0.000681	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—ALB—multiple sclerosis	0.000175	0.000656	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IL2RA—multiple sclerosis	0.00017	0.000635	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—APOE—multiple sclerosis	0.00017	0.000635	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000153	0.000573	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—BCHE—multiple sclerosis	0.000152	0.00057	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.00015	0.000563	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.000148	0.000552	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—POMC—multiple sclerosis	0.000146	0.000545	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CD86—multiple sclerosis	0.000135	0.000507	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ALB—multiple sclerosis	0.000133	0.000497	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000123	0.00046	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—ALB—multiple sclerosis	0.000123	0.000459	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—BCHE—multiple sclerosis	0.000122	0.000457	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CCR5—multiple sclerosis	0.00012	0.00045	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HLA-A—multiple sclerosis	0.000117	0.000439	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000111	0.000414	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—APOE—multiple sclerosis	0.000109	0.000409	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000106	0.000397	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IL2—multiple sclerosis	9.94e-05	0.000372	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CD80—multiple sclerosis	9.88e-05	0.00037	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.24e-05	0.000346	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—APOE—multiple sclerosis	9.15e-05	0.000343	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TYK2—multiple sclerosis	8.34e-05	0.000312	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—POMC—multiple sclerosis	7.86e-05	0.000295	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TGFB1—multiple sclerosis	7.75e-05	0.00029	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—MAPK1—multiple sclerosis	7.6e-05	0.000285	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CD4—multiple sclerosis	7.55e-05	0.000283	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—APOE—multiple sclerosis	7.34e-05	0.000275	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ALB—multiple sclerosis	7.17e-05	0.000269	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—POMC—multiple sclerosis	6.31e-05	0.000236	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—STAT3—multiple sclerosis	5.84e-05	0.000219	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ALB—multiple sclerosis	5.75e-05	0.000215	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MYC—multiple sclerosis	5.43e-05	0.000203	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TGFB1—multiple sclerosis	5.42e-05	0.000203	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MAPK1—multiple sclerosis	5.31e-05	0.000199	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—IL6—multiple sclerosis	4.08e-05	0.000153	CbGpPWpGaD
